-
1
-
-
21044439959
-
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
-
Anderlini, P., Saliba, R., Acholonu, S., Okoroji, G.J., Donato, M., Giralt, S., Andersson, B., Ueno, N.T., Khouri, I., De Lima, M., Hosing, C., Ippolito, C., Romaguera, J., Rodriguez, M.A., Pro, B., Fayad, L., Goy, A., Younes, A. & Champlin, R.E. (2005) Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplantation, 35, 943-951.
-
(2005)
Bone Marrow Transplantation
, vol.35
, pp. 943-951
-
-
Anderlini, P.1
Saliba, R.2
Acholonu, S.3
Okoroji, G.J.4
Donato, M.5
Giralt, S.6
Andersson, B.7
Ueno, N.T.8
Khouri, I.9
De Lima, M.10
Hosing, C.11
Ippolito, C.12
Romaguera, J.13
Rodriguez, M.A.14
Pro, B.15
Fayad, L.16
Goy, A.17
Younes, A.18
Champlin, R.E.19
-
2
-
-
24944446863
-
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens
-
Ardeshna, K.M., Kakouros, N., Qian, W., Powell, M.G., Saini, N., D'Sa, S., Mackinnon, S., Hoskin, P.J., Goldstone, A.H. & Linch, D.C. (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. British Journal of Haematology, 130, 363-372.
-
(2005)
British Journal of Haematology
, vol.130
, pp. 363-372
-
-
Ardeshna, K.M.1
Kakouros, N.2
Qian, W.3
Powell, M.G.4
Saini, N.5
D'Sa, S.6
Mackinnon, S.7
Hoskin, P.J.8
Goldstone, A.H.9
Linch, D.C.10
-
3
-
-
0035349002
-
Identification factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease
-
Canales, M.A., Fernandez-Jimenez, M.C., Martin, M.C., Arrieta, R., Cabellero, M.D., Diez, J., Quevedo, E., Garcia-Bustos, J., San Miguel, J.F. & Hernandez-Navarro, F. (2001) Identification factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica, 86, 494-498.
-
(2001)
Haematologica
, vol.86
, pp. 494-498
-
-
Canales, M.A.1
Fernandez-Jimenez, M.C.2
Martin, M.C.3
Arrieta, R.4
Cabellero, M.D.5
Diez, J.6
Quevedo, E.7
Garcia-Bustos, J.8
San Miguel, J.F.9
Hernandez-Navarro, F.10
-
4
-
-
80054101992
-
Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL)
-
Abstract 8031.
-
Chen, R.W., Gopal, A.K., Smith, S.E., Ansell, S.M., Rosenblatt, J.D., Savage, K.J., Engert, A., Larsen, E.K., Kennedy, D.A., Sievers, E.L. & Younes, A. (2011) Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL). Journal of Clinical Oncology, 29(Suppl 15), Abstract 8031.
-
(2011)
Journal of Clinical Oncology
, vol.29
, Issue.SUPPL. 15
-
-
Chen, R.W.1
Gopal, A.K.2
Smith, S.E.3
Ansell, S.M.4
Rosenblatt, J.D.5
Savage, K.J.6
Engert, A.7
Larsen, E.K.8
Kennedy, D.A.9
Sievers, E.L.10
Younes, A.11
-
5
-
-
33947496614
-
Revised response criteria for malignant lymphoma
-
Cheson, B., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M. & Diehl, V. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579-586.
-
(2007)
Journal of Clinical Oncology
, vol.25
, pp. 579-586
-
-
Cheson, B.1
Pfistner, B.2
Juweid, M.E.3
Gascoyne, R.D.4
Specht, L.5
Horning, S.J.6
Coiffier, B.7
Fisher, R.I.8
Hagenbeek, A.9
Zucca, E.10
Rosen, S.T.11
Stroobants, S.12
Lister, T.A.13
Hoppe, R.T.14
Dreyling, M.15
Tobinai, K.16
Vose, J.M.17
Connors, J.M.18
Federico, M.19
Diehl, V.20
more..
-
6
-
-
0026631135
-
Mini-BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease
-
Chopra, R., Linch, D.C., McMillan, A.K., Blair, S., Patterson, K.G., Moir, D., Richards, J.D., Cervi, P., Kinsey, S. & Goldstone, A.H. (1992) Mini-BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease. British Journal of Haematology, 81, 197-202.
-
(1992)
British Journal of Haematology
, vol.81
, pp. 197-202
-
-
Chopra, R.1
Linch, D.C.2
McMillan, A.K.3
Blair, S.4
Patterson, K.G.5
Moir, D.6
Richards, J.D.7
Cervi, P.8
Kinsey, S.9
Goldstone, A.H.10
-
7
-
-
0028819356
-
Mini-BEAM as salvage therapy for refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation
-
Colwill, R., Crump, M., Couture, F., Danish, R., Stewart, A.K., Sutton, D.M., Scott, J.G., Sutcliffe, S.B., Brandwein, J.M. & Keating, A. (1995) Mini-BEAM as salvage therapy for refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. Journal of Clinical Oncology, 13, 396-402.
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 396-402
-
-
Colwill, R.1
Crump, M.2
Couture, F.3
Danish, R.4
Stewart, A.K.5
Sutton, D.M.6
Scott, J.G.7
Sutcliffe, S.B.8
Brandwein, J.M.9
Keating, A.10
-
8
-
-
80054750428
-
R-CHOP14 versus R-CHOP 21: result of a randomized phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma
-
(ASCO Meeting Abstracts)
-
Cunningham, D., Smith, P., Mouncey, P., Qian, W., Jack, S., Pocock, C., Ardeshna, K., Radford, J.A., Davies, A.J., McMillan, A. & Linch, D.C. (2011) R-CHOP14 versus R-CHOP 21: result of a randomized phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma. Journal of Clinical Oncology (ASCO Meeting Abstracts), 29, 8000.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 8000
-
-
Cunningham, D.1
Smith, P.2
Mouncey, P.3
Qian, W.4
Jack, S.5
Pocock, C.6
Ardeshna, K.7
Radford, J.A.8
Davies, A.J.9
McMillan, A.10
Linch, D.C.11
-
9
-
-
71049118685
-
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study
-
Engert, A., Diehl, V., Franklin, J., Lohri, A., Dorken, B., Ludwig, W.D., Koch, P., Hanel, M., Pfreundschuh, M., Wilhelm, M., Trumper, L., Aulitzky, W.E., Bentz, M., Rummel, M., Sezer, O., Muller-Hermelink, H.K., Hasenclever, D. & Loffler, M. (2009) Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study. Journal of Clinical Oncology, 27, 4548-4554.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 4548-4554
-
-
Engert, A.1
Diehl, V.2
Franklin, J.3
Lohri, A.4
Dorken, B.5
Ludwig, W.D.6
Koch, P.7
Hanel, M.8
Pfreundschuh, M.9
Wilhelm, M.10
Trumper, L.11
Aulitzky, W.E.12
Bentz, M.13
Rummel, M.14
Sezer, O.15
Muller-Hermelink, H.K.16
Hasenclever, D.17
Loffler, M.18
-
10
-
-
12144286610
-
FDG-PET/CT in re-staging of patients with lymphoma
-
Freudenberg, L.S., Antoch, G., Schutt, P., Beyer, T., Jentzen, W., Muller, S.P., Gorges, R., Nowrousian, M.R., Bockisch, A. & Debatin, J.F. (2004) FDG-PET/CT in re-staging of patients with lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 31, 325-329.
-
(2004)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.31
, pp. 325-329
-
-
Freudenberg, L.S.1
Antoch, G.2
Schutt, P.3
Beyer, T.4
Jentzen, W.5
Muller, S.P.6
Gorges, R.7
Nowrousian, M.R.8
Bockisch, A.9
Debatin, J.F.10
-
11
-
-
0030842784
-
Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation
-
Girouard, C., Dufresne, J., Imrie, K., Stewart, A.K., Brandwein, J., Prince, H.M., Pantolony, D., Keating, A. & Crump, M. (1997) Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Annals of Oncology, 8, 675-680.
-
(1997)
Annals of Oncology
, vol.8
, pp. 675-680
-
-
Girouard, C.1
Dufresne, J.2
Imrie, K.3
Stewart, A.K.4
Brandwein, J.5
Prince, H.M.6
Pantolony, D.7
Keating, A.8
Crump, M.9
-
12
-
-
0024423332
-
Effectiveness of high-dose chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy
-
Gribben, J.G., Goldstone, A.H., Linch, D.C., Taghipour, G., McMillan, A.K., Souhami, R.L., Earl, H. & Richards, J.D. (1989) Effectiveness of high-dose chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. Journal of Clinical Oncology, 7, 1621-1629.
-
(1989)
Journal of Clinical Oncology
, vol.7
, pp. 1621-1629
-
-
Gribben, J.G.1
Goldstone, A.H.2
Linch, D.C.3
Taghipour, G.4
McMillan, A.K.5
Souhami, R.L.6
Earl, H.7
Richards, J.D.8
-
13
-
-
34250223441
-
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma
-
Jabbour, E., Hosing, C., Ayers, G., Nunez, R., Anderlini, P., Pro, B., Younes, A., Hagemeister, F., Kwah, L. & Fayad, L. (2007) Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer, 109, 2481-2489.
-
(2007)
Cancer
, vol.109
, pp. 2481-2489
-
-
Jabbour, E.1
Hosing, C.2
Ayers, G.3
Nunez, R.4
Anderlini, P.5
Pro, B.6
Younes, A.7
Hagemeister, F.8
Kwah, L.9
Fayad, L.10
-
14
-
-
77954709859
-
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma; survival data from the UKLG LY09 randomized control trial (ISRCTN97144519)
-
Johnson, P.W., Sydes, M.R., Hancock, B.W., Cullen, M., Radford, J.A. & Stenning, S.P. (2010) Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma; survival data from the UKLG LY09 randomized control trial (ISRCTN97144519). Journal of Clinical Oncology, 28, 3352-3359.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 3352-3359
-
-
Johnson, P.W.1
Sydes, M.R.2
Hancock, B.W.3
Cullen, M.4
Radford, J.A.5
Stenning, S.P.6
-
15
-
-
79951890275
-
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma
-
Josting, A., Muller, H., Borchmann, P., Baars, J.W., Metzner, B., Dohner, H., Aurer, I., Smardova, L., Fischer, T., Niederwieser, D., Schafer-Eckhart, K., Schmitz, N., Sureda, A., Glossmann, J., Diehl, V., Dejong, D., Hansmann, M.L., Raemaekers, J. & Engert, A. (2010) Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma. Journal of Clinical Oncology, 28, 5074-5080.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 5074-5080
-
-
Josting, A.1
Muller, H.2
Borchmann, P.3
Baars, J.W.4
Metzner, B.5
Dohner, H.6
Aurer, I.7
Smardova, L.8
Fischer, T.9
Niederwieser, D.10
Schafer-Eckhart, K.11
Schmitz, N.12
Sureda, A.13
Glossmann, J.14
Diehl, V.15
Dejong, D.16
Hansmann, M.L.17
Raemaekers, J.18
Engert, A.19
-
16
-
-
33947603127
-
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma
-
Kasamon, Y.L., Jones, R.J. & Wahl, R.L. (2007) Integrating PET and PET/CT into the risk-adapted therapy of lymphoma. Journal of Nuclear Medicine, 48(Suppl. 1), 19S-27S.
-
(2007)
Journal of Nuclear Medicine
, vol.48
, Issue.SUPPL. 1
-
-
Kasamon, Y.L.1
Jones, R.J.2
Wahl, R.L.3
-
17
-
-
30744445985
-
Similar response rates and earlier progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine etoposide, cytarabine and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
-
Kuruvilla, J., Nagy, T., Pintilie, M., Tsang, R., Keating, A. & Crump, M. (2006) Similar response rates and earlier progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine etoposide, cytarabine and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma. Cancer, 106, 353-360.
-
(2006)
Cancer
, vol.106
, pp. 353-360
-
-
Kuruvilla, J.1
Nagy, T.2
Pintilie, M.3
Tsang, R.4
Keating, A.5
Crump, M.6
-
18
-
-
77951008602
-
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma
-
Lambert, J.R., Bomanji, J.B., Peggs, K.S., Thomson, K.J., Chakraverty, R.K., Fielding, A.K., Kottaridis, P.D., Roughton, M., Morris, E.C., Goldstone, A.H., Linch, D.C., Ell, P.J. & Mackinnon, S. (2010) Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. Blood, 115, 2763-2768.
-
(2010)
Blood
, vol.115
, pp. 2763-2768
-
-
Lambert, J.R.1
Bomanji, J.B.2
Peggs, K.S.3
Thomson, K.J.4
Chakraverty, R.K.5
Fielding, A.K.6
Kottaridis, P.D.7
Roughton, M.8
Morris, E.C.9
Goldstone, A.H.10
Linch, D.C.11
Ell, P.J.12
Mackinnon, S.13
-
19
-
-
0012457633
-
Hodgkin's lymphoma: choice of therapy and late complications
-
Linch, D.C., Gosedn, R.G., Tulandi, T., Tan, S.L. & Hancock, S.L. (2000) Hodgkin's lymphoma: choice of therapy and late complications. American Society of Haematology Educational Program, 2, 205-221.
-
(2000)
American Society of Haematology Educational Program
, vol.2
, pp. 205-221
-
-
Linch, D.C.1
Gosedn, R.G.2
Tulandi, T.3
Tan, S.L.4
Hancock, S.L.5
-
20
-
-
0035001460
-
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
-
Martin, A., Fernandez-Jimenez, M.C., Caballero, M.D., Canales, M.A., Perez-Simon, J.A., Garcia de Bustos, J., Vazquez, L., Hernandez-Navarro, F. & San Miguel, J.F. (2001) Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease. British Journal of Haematology, 113, 161-171.
-
(2001)
British Journal of Haematology
, vol.113
, pp. 161-171
-
-
Martin, A.1
Fernandez-Jimenez, M.C.2
Caballero, M.D.3
Canales, M.A.4
Perez-Simon, J.A.5
Garcia de Bustos, J.6
Vazquez, L.7
Hernandez-Navarro, F.8
San Miguel, J.F.9
-
21
-
-
10244242523
-
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation for relapsed and refractory non-Hodgkin lymphoma
-
Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G.M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A. & Mackinnon, S. (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation for relapsed and refractory non-Hodgkin lymphoma. Blood, 104, 3865-3871.
-
(2004)
Blood
, vol.104
, pp. 3865-3871
-
-
Morris, E.1
Thomson, K.2
Craddock, C.3
Mahendra, P.4
Milligan, D.5
Cook, G.6
Smith, G.M.7
Parker, A.8
Schey, S.9
Chopra, R.10
Hatton, C.11
Tighe, J.12
Hunter, A.13
Peggs, K.14
Linch, D.15
Goldstone, A.16
Mackinnon, S.17
-
22
-
-
58049219093
-
Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group
-
Morschhauser, F., Brice, P., Ferme, C., Divine, M., Salles, G., Bouabdallah, R., Sebban, C., Voillat, L., Casanovas, O., Stamatoullas, A., Bouabdallah, K., Andre, M., Jais, J.P., Cazals-Hatem, C. & Gisselbrecht, C. (2008) Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group. Journal of Clinical Oncology, 26, 5980-5987.
-
(2008)
Journal of Clinical Oncology
, vol.26
, pp. 5980-5987
-
-
Morschhauser, F.1
Brice, P.2
Ferme, C.3
Divine, M.4
Salles, G.5
Bouabdallah, R.6
Sebban, C.7
Voillat, L.8
Casanovas, O.9
Stamatoullas, A.10
Bouabdallah, K.11
Andre, M.12
Jais, J.P.13
Cazals-Hatem, C.14
Gisselbrecht, C.15
-
23
-
-
1542359509
-
Effectiveness of high dose chemotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease
-
Moskowitz, C.H., Kewalramani, T., Nimer, S.D., Gonzalez, M., Zelenetz, A.D. & Yahalom. (2004) Effectiveness of high dose chemotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease. British Journal of Haematology, 124, 645-652.
-
(2004)
British Journal of Haematology
, vol.124
, pp. 645-652
-
-
Moskowitz, C.H.1
Kewalramani, T.2
Nimer, S.D.3
Gonzalez, M.4
Zelenetz, A.D.5
Yahalom6
-
24
-
-
78649748606
-
Pretransplanation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
-
Moskowitz, A., Yahalom, J., Kewalramani, T., Maragulia, J.C., Vanak, J.M., Zelenetz, A.D. & Moskowitz, C.H. (2010) Pretransplanation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood, 116, 4934-4937.
-
(2010)
Blood
, vol.116
, pp. 4934-4937
-
-
Moskowitz, A.1
Yahalom, J.2
Kewalramani, T.3
Maragulia, J.C.4
Vanak, J.M.5
Zelenetz, A.D.6
Moskowitz, C.H.7
-
25
-
-
46749090038
-
Current role of gemcitabine in the treatment of Hodgkin lymphoma
-
Oki, Y. & Younes, A. (2008) Current role of gemcitabine in the treatment of Hodgkin lymphoma. Leukaemia and Lymphoma, 49, 883-889.
-
(2008)
Leukaemia and Lymphoma
, vol.49
, pp. 883-889
-
-
Oki, Y.1
Younes, A.2
-
26
-
-
20444410110
-
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
-
Peggs, K.S., Hunter, A., Chopra, R., Parker, A., Mahendra, P., Milligan, D., Craddock, C., Pettengell, R., Dogan, A., Thomson, K.J., Morris, E.C., Hale, G., Waldmann, H., Goldstone, A.H., Linch, D.C. & Mackinnon, S. (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet, 365, 1934-1941.
-
(2005)
The Lancet
, vol.365
, pp. 1934-1941
-
-
Peggs, K.S.1
Hunter, A.2
Chopra, R.3
Parker, A.4
Mahendra, P.5
Milligan, D.6
Craddock, C.7
Pettengell, R.8
Dogan, A.9
Thomson, K.J.10
Morris, E.C.11
Hale, G.12
Waldmann, H.13
Goldstone, A.H.14
Linch, D.C.15
Mackinnon, S.16
-
27
-
-
0023197665
-
High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma
-
Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.Y., Colombat, P., Goldstone, A.H., Gorin, N.C., Flesh, M., Laporte, P., Maraninchi, D., Pico, J., Bosly, A., Andersen, C., Schots, R., Biron, P., Cabanillas, F. & Dicke, K. (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316, 1493-1498.
-
(1987)
New England Journal of Medicine
, vol.316
, pp. 1493-1498
-
-
Philip, T.1
Armitage, J.O.2
Spitzer, G.3
Chauvin, F.4
Jagannath, S.5
Cahn, J.Y.6
Colombat, P.7
Goldstone, A.H.8
Gorin, N.C.9
Flesh, M.10
Laporte, P.11
Maraninchi, D.12
Pico, J.13
Bosly, A.14
Andersen, C.15
Schots, R.16
Biron, P.17
Cabanillas, F.18
Dicke, K.19
-
28
-
-
33644687850
-
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease
-
Seyfarth, B., Josting, A., Dreyling, M. & Schmitz, N. (2006) Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease. British Journal of Haematology, 133, 3-18.
-
(2006)
British Journal of Haematology
, vol.133
, pp. 3-18
-
-
Seyfarth, B.1
Josting, A.2
Dreyling, M.3
Schmitz, N.4
-
29
-
-
0037630376
-
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation
-
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Balzarini, J., Wolf-Peeters, C.D., Mortelmans, L. & Verhoef, G. (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood, 102, 53-59.
-
(2003)
Blood
, vol.102
, pp. 53-59
-
-
Spaepen, K.1
Stroobants, S.2
Dupont, P.3
Vandenberghe, P.4
Maertens, J.5
Bormans, G.6
Balzarini, J.7
Wolf-Peeters, C.D.8
Mortelmans, L.9
Verhoef, G.10
-
30
-
-
84860842155
-
FDA approves brentuximab vedotin in two lymphoma indications
-
Stenger, M. (2011) FDA approves brentuximab vedotin in two lymphoma indications. ASCO Post, 2.
-
(2011)
ASCO Post
, vol.2
-
-
Stenger, M.1
-
31
-
-
38649089434
-
Reduced-intensity conditioning compared to conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma; an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
-
Sureda, A., Robinson, S., Canals, C., Carella, A.M., Boogaerts, M.A., Cabellero, D., Hunter, A.E., Kanz, L., Slavin, S., Cornelissen, J.J., Gramatzki, M., Niederwieser, D., Russell, N.H. & Schmitz, N. (2008) Reduced-intensity conditioning compared to conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma; an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 26, 455-462.
-
(2008)
Journal of Clinical Oncology
, vol.26
, pp. 455-462
-
-
Sureda, A.1
Robinson, S.2
Canals, C.3
Carella, A.M.4
Boogaerts, M.A.5
Cabellero, D.6
Hunter, A.E.7
Kanz, L.8
Slavin, S.9
Cornelissen, J.J.10
Gramatzki, M.11
Niederwieser, D.12
Russell, N.H.13
Schmitz, N.14
-
32
-
-
33746314845
-
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation
-
Svoboda, J., Andreadis, C., Elstrom, R., Chong, E.A., Downs, L.H., Berkowitz, A., Luger, S.M., Porter, D.L., Nasta, S., Tsai, D., Loren, A.W., Siegel, D.L., Glatstein, E., Alavi, A., Stadtmauer, E.A. & Schuster, S.J. (2006) Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplantation, 38, 211-216.
-
(2006)
Bone Marrow Transplantation
, vol.38
, pp. 211-216
-
-
Svoboda, J.1
Andreadis, C.2
Elstrom, R.3
Chong, E.A.4
Downs, L.H.5
Berkowitz, A.6
Luger, S.M.7
Porter, D.L.8
Nasta, S.9
Tsai, D.10
Loren, A.W.11
Siegel, D.L.12
Glatstein, E.13
Alavi, A.14
Stadtmauer, E.A.15
Schuster, S.J.16
-
33
-
-
58549104567
-
Favourable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma
-
Thomson, K.J., Morris, E.C., Bloor, A., Cook, G., Milligan, D., Parker, A., Clark, F., Yung, L., Linch, D.C., Chakraverty, R., Peggs, K.S. & Mackinnon, S. (2009) Favourable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 27, 426-432.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 426-432
-
-
Thomson, K.J.1
Morris, E.C.2
Bloor, A.3
Cook, G.4
Milligan, D.5
Parker, A.6
Clark, F.7
Yung, L.8
Linch, D.C.9
Chakraverty, R.10
Peggs, K.S.11
Mackinnon, S.12
-
34
-
-
84876203658
-
Response-adjusted transplantation in primary resistant and relapsed Hodgkin lymphoma
-
(ASH annual meeting abstracts)
-
Thomson, K., Kayani, I., Ardeshna, K.M., Morris, E., Hough, R., Goldstone, A.H., Linch, D.C. & Peggs, K.S. (2011) Response-adjusted transplantation in primary resistant and relapsed Hodgkin lymphoma. Blood (ASH annual meeting abstracts), 118, 336.
-
(2011)
Blood
, vol.118
, pp. 336
-
-
Thomson, K.1
Kayani, I.2
Ardeshna, K.M.3
Morris, E.4
Hough, R.5
Goldstone, A.H.6
Linch, D.C.7
Peggs, K.S.8
-
35
-
-
0031024323
-
Progenitor-cell mobilization after low dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
-
Watts, M.J., Sullivan, A.M., Jamieson, E., Pearce, R., Fielding, A., Devereux, S., Goldstone, A.H. & Linch, D.C. (1997) Progenitor-cell mobilization after low dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. Journal of Clinical Oncology, 15, 535-546.
-
(1997)
Journal of Clinical Oncology
, vol.15
, pp. 535-546
-
-
Watts, M.J.1
Sullivan, A.M.2
Jamieson, E.3
Pearce, R.4
Fielding, A.5
Devereux, S.6
Goldstone, A.H.7
Linch, D.C.8
|